Sfmg LLC raised its position in shares of VanEck Semiconductor ETF (NASDAQ:SMH – Free Report) by 2.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,240 shares of the company’s stock after purchasing an additional 100 shares during the period. Sfmg LLC’s holdings in VanEck Semiconductor ETF were worth $1,105,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Silicon Valley Capital Partners acquired a new stake in shares of VanEck Semiconductor ETF in the first quarter worth about $25,000. Chilton Capital Management LLC acquired a new stake in shares of VanEck Semiconductor ETF in the second quarter worth about $26,000. Innealta Capital LLC acquired a new stake in shares of VanEck Semiconductor ETF in the second quarter worth about $28,000. TD Capital Management LLC acquired a new stake in shares of VanEck Semiconductor ETF in the second quarter worth about $29,000. Finally, Creekmur Asset Management LLC acquired a new stake in shares of VanEck Semiconductor ETF in the fourth quarter worth about $30,000.
VanEck Semiconductor ETF Price Performance
Shares of NASDAQ:SMH opened at $243.40 on Wednesday. VanEck Semiconductor ETF has a fifty-two week low of $136.10 and a fifty-two week high of $283.07. The stock has a market capitalization of $21.89 billion, a P/E ratio of 18.82 and a beta of 1.35. The business has a 50-day moving average of $237.14 and a two-hundred day moving average of $237.38.
VanEck Semiconductor ETF Company Profile
The VanEck Semiconductor ETF (SMH) is an exchange-traded fund that is based on the MVIS US Listed Semiconductor 25 index, a market-cap-weighted index of 25 of the largest US-listed semiconductors companies. SMH was launched on May 5, 2000 and is managed by VanEck.
Featured Stories
- Five stocks we like better than VanEck Semiconductor ETF
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Stock Market Sectors: What Are They and How Many Are There?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for VanEck Semiconductor ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Semiconductor ETF and related companies with MarketBeat.com's FREE daily email newsletter.